Literature DB >> 33395240

Telemedicine for cancer care: implementation across a multicenter community oncology practice.

Debra Patt, Lalan Wilfong, Kristen Kanipe, R Steven Paulson.   

Abstract

PURPOSE: To describe onboarding and utilization of telemedicine across a large statewide community oncology practice and to evaluate trends, barriers, and opportunities in care delivery during the coronavirus disease 2019 pandemic.
METHODS: We describe telemedicine onboarding and utilization across a statewide oncology practice, covering 221 sites of service and more than 650 practitioners. We describe qualitatively the onboarding process of a diverse set of administrative, technical, and clinical partners. We describe quantitatively utilization throughout the practice. We describe a survey conducted to enlighten barriers and opportunities for optimal utilization.
RESULTS: Multistakeholder education was directed to clinical teams, administrative and technical support staff, and patients through webinars and team meetings. Utilization was high from April through October 2020, representing 15% to 20% of new-patient visits and 20% to 25% of established-patient visits. In a survey offered to all clinicians, 96% of respondents indicated they are using telemedicine, with 33% using it for more than 25% of patient encounters. Among respondents, 59% reported that the use of telemedicine helps expedite diagnosis and treatment more than seeing patients in person in the clinic, 55% of respondents managed urgent issues by telemedicine, 80% believed that patients benefited From urgent assessment by telemedicine, and 57% believed an emergency department visit or a hospitalization was avoided because of a telemedicine visit. Most clinicians reported that patients enjoy benefits of telemedicine because of decreased exposure risk, decreased transportation requirements, and ease of including caregivers in the visit with the treating clinician. The most common barriers to patients accessing telemedicine were technical challenges and broadband access. Despite this, less than 5% of respondents routinely use telephone-only communication, as most typically use bimodal audio/video communication. Many clinicians have expansion ideas on how telemedicine can further expand the longitudinal care delivery for our patient population.
CONCLUSIONS: Telemedicine can be implemented successfully across a large statewide oncology practice and service a high volume of patients. Clinicians utilize telemedicine for new and established patients with minimal dysfunction. Clinicians believe patients benefit From telemedicine For new, established, and urgent care visits. Broadband access functionality should be explored to optimally serve our patient population.

Entities:  

Year:  2020        PMID: 33395240     DOI: 10.37765/ajmc.2020.88560

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  8 in total

Review 1.  Mitigating the Impact of the COVID-19 Pandemic on Adult Cancer Patients through Telehealth Adoption: A Systematic Review.

Authors:  Aileen Murphy; Ann Kirby; Amy Lawlor; Frances J Drummond; Ciara Heavin
Journal:  Sensors (Basel)       Date:  2022-05-09       Impact factor: 3.847

2.  Factors Influencing Telemedicine Use at a Northern New England Cancer Center During the COVID-19 Pandemic.

Authors:  Matthew B Mackwood; Tor D Tosteson; Jennifer A Alford-Teaster; Kevin M Curtis; Mary L Lowry; Jennifer A Snide; Wenyan Zhao; Anna N A Tosteson
Journal:  JCO Oncol Pract       Date:  2022-04-21

Review 3.  Practical guidance for telemedicine use in neuro-oncology.

Authors:  Roy E Strowd; Erin M Dunbar; Hui K Gan; Sylvia Kurz; Justin T Jordan; Jacob J Mandel; Nimish A Mohile; Kathryn S Nevel; Jennie W Taylor; Nicole J Ullrich; Mary R Welch; Andrea Wasilewski; Maciej M Mrugala
Journal:  Neurooncol Pract       Date:  2022-01-17

Review 4.  Telehealth Utilization During the COVID-19 Pandemic: A Preliminary Selective Review.

Authors:  Amelia Harju; Jonathan Neufeld
Journal:  Telemed Rep       Date:  2022-02-03

5.  Cancer patients' satisfaction with telehealth during the COVID-19 pandemic.

Authors:  Samantha R Paige; Gemme Campbell-Salome; Jordan Alpert; Merry Jennifer Markham; Martina Murphy; Eve Heffron; Chris Harle; Sijia Yue; Wei Xue; Carma L Bylund
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

6.  Inequity in Telemedicine Use Among Patients with Cancer in the Deep South During the COVID-19 Pandemic.

Authors:  Connie C Shao; M Chandler McLeod; Lauren T Gleason; Isabel C Dos Santos Marques; Daniel I Chu; Eric L Wallace; Mona N Fouad; Sushanth Reddy
Journal:  Oncologist       Date:  2022-07-05       Impact factor: 5.837

7.  Oncology patients' communication experiences during COVID-19: comparing telehealth consultations to in-person visits.

Authors:  Richard L Street; Katherine Treiman; Elissa C Kranzler; Rebecca Moultrie; Laura Arena; Nicole Mack; Reese Garcia
Journal:  Support Care Cancer       Date:  2022-02-09       Impact factor: 3.359

8.  Adoption of Telemedicine in a Rural US Cancer Center Amid the COVID-19 Pandemic: Qualitative Study.

Authors:  Matthew Mackwood; Rebecca Butcher; Danielle Vaclavik; Jennifer A Alford-Teaster; Kevin M Curtis; Mary Lowry; Tor D Tosteson; Wenyan Zhao; Anna N A Tosteson
Journal:  JMIR Cancer       Date:  2022-08-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.